The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Factors associated with lymphedema in patients/women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection on a prospective clinical trial.
 
Judy Caroline Boughey
Research Funding - Myriad Genetics (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending - METHODS AND MATERIALS FOR ASSESSING CHEMOTHERAPY RESPONSIVENESS AND TREATING CANCER (Inst)
 
Karla V. Ballman
Consulting or Advisory Role - ARIAD; Medtronic
Patents, Royalties, Other Intellectual Property - Immune enrichment signature for response to trastuzumab in HER2+ breast cancer (Inst); Prostate cancer signature patent (Inst)
Expert Testimony - Janssen Oncology; Janssen Oncology
 
Linda Mackie McCall
No Relationships to Disclose
 
Henry Mark Kuerer
Speakers' Bureau - PER
Research Funding - Genomic Health (Inst)
Patents, Royalties, Other Intellectual Property - McGraw-Hill Publishing; NEJM Group
 
Kelly Hunt
Consulting or Advisory Role - Armada Health Care
Research Funding - Endomagnetics (Inst)
 
Jane M. Armer
No Relationships to Disclose